Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomasAlicia León‐Castillo, Tjalling Bosse, Jessica N. McAlpine et al.|The Journal of Pathology|2019Cited by 401
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trialMark T. Drayson, Janet Dunn, Stella Bowcock et al.|The Lancet Oncology|2019Cited by 160